Loading clinical trials...
Loading clinical trials...
Expanded access, open label study at a single dose level in patients with CED that in the opinion of the investigators might benefit from TTHX1114
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Trefoil Therapeutics, Inc.
NCT05136443 · Corneal Endothelial Dystrophy, Corneal Edema
NCT00744796 · Corneal Edema Secondary to Corneal Endothelial Dystrophy
NCT04191629 · Corneal Edema, Fuchs Dystrophy, and more
Trefoil Study Site
Atlanta, Georgia
Trefoil Study Site
Washington, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions